Find drugs by alphabetical list:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
View All
Elan's Loss Widens After Setting Aside $206 Million in U.S. for Zonegran - Bloomberg
RTE.ieElan's Loss Widens After Setting Aside $206 Million in U.S. for ZonegranBloomberg... quarter loss after it set aside $206.3 million to settle US government charges linked to the sale and marketing of the Zonegran epilepsy treatment. ...Elan Net Loss Widens On Legal Charge, Keeps OutlookWall Street JournalS&P: Elan Corp. PLC Medicaid Settlement Announcement Will Not Affect Ratings ...PharmaLive.com (press release)Elan sales up 10%Insideireland.ieIrish Times -BNET -Business Financial News Wireall 51 news articles »
Elan to settle Zonegran investigation for $204M - BusinessWeek
Elan to settle Zonegran investigation for $204MBusinessWeekPLC said Thursday it agreed to pay $203.5 million to settle investigations into sales and marketing practices related to the epilepsy drug Zonegran. ...
Elan expects Zonegran marketing probe to cost it $206m - InPharm (blog)
Elan expects Zonegran marketing probe to cost it $206mInPharm (blog)Elan Corporation expects to pay $206.3 million to settle a US government investigation into the way it marketed its anti-epileptic drug Zonegran. ...Elan to settle over past Zonegran marketing activities in USA, with potential ...The Pharma Letterall 2 news articles »
Elan to pay $200 mln fine after US probe - Reuters
Elan to pay $200 mln fine after US probeReuters"Additionally, the proposed resolution of the Zonegran investigation could give rise to other litigation by state government entities or private parties."

Last updated on: Jan 24, 2007
| Brand Name: | Zonegran |
| Active Ingredient: | zonisamide |
| Strength(s): | 100mg |
| Dosage Form(s): | Capsule |
| Company Name: | Elan Pharmaceuticals |
| Availability: | Prescription only |
| *Date Approved by FDA: | March 27, 2000 |
| *Approval by FDA does not mean that the drug will be immediately marketed and available for consumers at this time. This information is provided by the U.S. Food & Drug Administration. For more information about this drug, click here. | |
ZONEGRAN is a medicine to treat partial seizures in adults. It is taken with other seizure medicines to help control seizures.
Who should not take Zonegran?
Do not take Zonegran if you are allergic to any sulfa drugs (for example, Bactrim or Septra).
Special Warning(s) with Zonegran:
Some people taking ZONEGRAN can get serious reactions including:
Talk to your doctor first before stopping Zonegran or any other seizure medicine. Stopping a seizure medicine all at once can cause status epilepticus, a serious problem.
Zonegran can cause drowsiness and coordination problems. Do not drive or operate dangerous machinery until you know how Zonegran affects you.
What should I tell my doctor or health care provider?
Tell your doctor about any other medicines you may be taking, including non-prescription medicines.
ZONEGRAN may cause birth defects. Tell your doctor if you are pregnant or plan to become pregnant.
Tell your doctor if you are nursing or planning to nurse your baby. It is not known whether Zonegran is passed through breast milk to the baby.
What are some possible side effects of Zonegran? (This is NOT a complete list of side effects reported with Zonegran. Your health care provider can discuss with you a more complete list of side effects.)
Common side effects include:
Accupril
Actonel
Actos
Allegra
Altace
Atenolol
Avandia
Celebrex
Celexa
Cialis
Coreg
Cozaar
Crestor
Diovan
Effexor
Evista
Flomax
Fluoxetine
Fosamax
Glucophage
Latisse
Levitra
Levoxyl
Lexapro
Lipitor
Lisinopril
Metformin
Neurontin
Nexium
Norvasc
Paxil
Plavix
Pravachol
Premarin
Prevacid
Prilosec
Propecia
Protonix
Prozac
Seroquel
Simvastatin
Singulair
Toprol-XL
Viagra
Zetia
Zithromax
Zocor
Zoloft
Zyprexa
Zyrtec